Bio-Path Holdings, Inc. (NASDAQ:BPTH) Sees Significant Increase in Short Interest

Bio-Path Holdings, Inc. (NASDAQ:BPTH) was the target of a large growth in short interest during the month of September. As of September 30th, there was short interest totaling 15,000 shares, a growth of 111.3% from the September 15th total of 7,100 shares. Based on an average daily volume of 229,400 shares, the short-interest ratio is currently 0.1 days. Based on an average daily volume of 229,400 shares, the short-interest ratio is currently 0.1 days.

Bio-Path Trading Up 19.9%

Shares of NASDAQ:BPTH opened at $0.08 on Tuesday. Bio-Path has a 52-week low of $0.05 and a 52-week high of $3.39. The company has a 50-day simple moving average of $0.09 and a 200 day simple moving average of $0.14.

About Bio-Path

Bio-Path Holdings, Inc operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology platform that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction.